Available Courses

Course

Injectable Cosmetic Workshop December 1, 2018

Little Rock, Arkansas | 12/01/18

By Invitation Only

Forefront Dermatology is hosting two Injectable Cosmetic Workshops on December 1, 2018 between 9AM and 4PM. The workshop includes lunch, a presentation from Dr. Victoria Negrete, and 3 hours of hands-on training.

More about this course >

Course

Injectable Cosmetic Workshop January 5, 2019

Detriot, Michigan | 1/05/19

By Invitation Only

Forefront Dermatology is hosting two Injectable Cosmetic Workshops on January 5, 2019 between 9AM and 4PM. The workshop includes lunch, a presentation from Dr. Victoria Negrete and Dr. Betsy Wernli, and 4 hours of hands-on training.

More about this course >

Publication Announcements

Publication

Dr. Joshua W. Hagen publishes “Nonmelanoma Skin Cancer Risk in Patients With Inflammatory Bowel Disease Undergoing Thiopurine Therapy: A Systematic Review of the Literature

The aim of this study was to systematically review current literature on NMSC risk in patients with IBD using thiopurine therapy.

More about this publication >

MD
Publication

Bailey Tayebi, MD – publishes Pernio paper

Congratulations to board-certified dermatologist and fellowship trained Mohs surgeon - Bailey Tayebi, MD from Forefront Dermatology on her recently published paper on "Pernio as the presenting sign of blast crisis in acute lymphoblastic leukemia".

More about this publication >

Kelli Hutchens
Publication

Kelli A. Hutchens, MD publishes Melanoma study

Congratulations to board-certified dermatopathologist Kelli A. Hutchens, MD from Forefront Dermatology on her recently published Melanoma study. Melanoma Research journal transcends many fields including dermatology, pathology, surgery, oncology, and basic science.

More about this publication >

Forefront Clinical Research

With an exceptional depth of expertise and a highly trained and experienced staff, the Forefront Clinical Research Center is currently conducting multiple trials in dermatology, including Phase 1 through Phase 4 studies.

Visit Our Clinical Research Site